TGF-β production has only rarely been associated with suppression mediated by B cells (33), but therapeutic IL-6 blockade in patients with rheumatoid arthritis leads to an increase in regulatory B cells producing TGF-β (34). Here, IL6 is linked to rheumatoid arthritis.